Filing Details

Accession Number:
0001019695-17-000027
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-08 10:17:14
Reporting Period:
2017-09-07
Accepted Time:
2017-09-08 10:17:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1019695 Arqule Inc ARQL Pharmaceutical Preparations (2834) 043221586
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436861 Paolo Pucci C/O Arqule, Inc.
1 Wall Street, 6Th Floor
Burlington MA 01803
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-07 1,101 $1.15 404,194 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $1.14 to $1.15. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.